1. Home
  2. ICUI vs CRVL Comparison

ICUI vs CRVL Comparison

Compare ICUI & CRVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • CRVL
  • Stock Information
  • Founded
  • ICUI 1984
  • CRVL 1987
  • Country
  • ICUI United States
  • CRVL United States
  • Employees
  • ICUI N/A
  • CRVL N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • CRVL Specialty Insurers
  • Sector
  • ICUI Health Care
  • CRVL Finance
  • Exchange
  • ICUI Nasdaq
  • CRVL Nasdaq
  • Market Cap
  • ICUI 3.2B
  • CRVL 3.8B
  • IPO Year
  • ICUI 1992
  • CRVL 1991
  • Fundamental
  • Price
  • ICUI $140.16
  • CRVL $75.97
  • Analyst Decision
  • ICUI Buy
  • CRVL
  • Analyst Count
  • ICUI 6
  • CRVL 0
  • Target Price
  • ICUI $183.60
  • CRVL N/A
  • AVG Volume (30 Days)
  • ICUI 290.1K
  • CRVL 159.6K
  • Earning Date
  • ICUI 11-06-2025
  • CRVL 11-04-2025
  • Dividend Yield
  • ICUI N/A
  • CRVL N/A
  • EPS Growth
  • ICUI N/A
  • CRVL 28.65
  • EPS
  • ICUI N/A
  • CRVL 2.02
  • Revenue
  • ICUI $2,320,363,000.00
  • CRVL $933,841,000.00
  • Revenue This Year
  • ICUI N/A
  • CRVL N/A
  • Revenue Next Year
  • ICUI N/A
  • CRVL N/A
  • P/E Ratio
  • ICUI N/A
  • CRVL $37.61
  • Revenue Growth
  • ICUI N/A
  • CRVL 10.43
  • 52 Week Low
  • ICUI $107.00
  • CRVL $70.47
  • 52 Week High
  • ICUI $196.26
  • CRVL $128.61
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 73.86
  • CRVL 50.92
  • Support Level
  • ICUI $116.21
  • CRVL $73.59
  • Resistance Level
  • ICUI $120.60
  • CRVL $79.43
  • Average True Range (ATR)
  • ICUI 4.88
  • CRVL 2.13
  • MACD
  • ICUI 1.92
  • CRVL 0.55
  • Stochastic Oscillator
  • ICUI 69.73
  • CRVL 51.42

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About CRVL CorVel Corp.

CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.

Share on Social Networks: